Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others
Regulatory updates from J&J (JNJ), Merck (MRK), Roche (RHHBY), Pfizer (PFE) and others. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Cli.....»»
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ"s New Plan to Resolve Talc Claims
The first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli.....»»
MarketWatch: Pfizer beat earnings but here’s why this analyst downgraded the stock to neutral
Mizuho Securities says the pharma giant needs its pipeline to deliver for investors to gain more comfort with Pfizer's outlook......»»
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc. read more.....»»
Pfizer Won’t Win the Coronavirus Pharma War
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pfizer st.....»»
Merck, Pfizer stock gains on earnings beats would add 23 points to the Dow"s price
Shares of Merck & Co. Inc. and Pfi.....»»
Pharma Earnings: Merck, Pfizer Trade Higher On Q3 Beats
Merck & Co (NYSE: MRK) and Pfizer (NYSE: PFE) both reported a third-quarter earnings beat Tuesday. Merck Merck shares were trading higher after the company reporte.....»»
Merck"s stock falls 2.0%, Pfizer"s drops 1.9% to pace the 4 of 30 Dow industrials components losing ground
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Bank Of America Hikes Pfizer Price Target, Estimates Citing Orphan Drug Catalysts
Large-cap pharma stocks have seen a mixed performance in year to date, and among this group, Pfizer Inc. (NYSE: PFE) is poised to benefit from some key second-half catalysts, according to an analyst at Bank of America Merrill Lynch. Lat.....»»
Johnson & Johnson Vs. Pfizer: Which Big Pharma Giant Is The Better Dividend Stock?
Johnson & Johnson Vs. Pfizer: Which Big Pharma Giant Is The Better Dividend Stock?.....»»
Merck vs. Pfizer: Which Stock is Better Before Q1 Earnings?
With both Merck and Pfizer are scheduled to report on May 1, this may be a good time to figure out which of these is a better stock. Investors are keenly awaiting earnings results from both Merck & Co., Inc. MRK and Pfizer, Inc. PFE.....»»
What to Look For in the Merck and Pfizer Reports Tuesday Morning
Both Pfizer and Merck are scheduled to release their most recent quarterly results before the markets open on Tuesday. These are the two biggest companies in the pharma industry and they can set the........»»
Apple Results, Fed Decision, Jobs Report In Focus; Merck, Pfizer Reports Mixed
The market got a checkup with Big Pharma earnings in focus as corporate reporting season .....»»
Why Pfizer and Merck Stock Both Slumped After Their Earnings Reports
Pfizer stock was down more than 4%, while Merck fell 2% despite beating profit expectation.....»»
Why Pfizer and Merck Both Slumped After Their Earnings Reports
Pfizer stock fell 4% in early Tuesday trading while Merck stock slipped about 1% after the two drug giants issued their quarterly earnings reports.....»»
AstraZeneca (AZN) Stock on Growth Path This Year: Here"s Why
AstraZeneca's (AZN) stock is up this year while the Large-Cap Pharma industry is witnessing a decline Shares of AstraZeneca, PLC AZN have risen 4.8% so far this year against the Large-Cap Pharma industry’s declin.....»»
3 Stocks Raising Hopes in Troubled Large-Cap Pharma Industry
InvestorPlace - Stock Market News, Stock.....»»